Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Zervixkarzinom: TMMR auch langfristig erfolgreich

  • 3 Accesses

This is a preview of subscription content, log in to check access.

Author information

Correspondence to Peter Leiner.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leiner, P. Zervixkarzinom: TMMR auch langfristig erfolgreich. Im Fokus Onkologie 23, 22–23 (2020). https://doi.org/10.1007/s15015-019-0999-0

Download citation